OSMR Antibodies

Santa Cruz Biotechnology features a diverse variety of OSMR monoclonal antibodies for investigating the Oncostatin M receptor (OSMR) in various biological processes. OSMR monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The Oncostatin M receptor belongs to the interleukin-6 receptor family and mediates the effects of oncostatin M, a cytokine involved in inflammation and hematopoiesis. OSMR plays a vital role in cell differentiation, proliferation, and survival, making it a key focus in cancer and disease research. Investigating OSMR signaling pathways can reveal potential therapeutic strategies for conditions like chronic inflammation and cancer. Researchers worldwide rely on OSMR monoclonal antibodies to advance their understanding of cellular mechanisms and disease progression. Characterization of OSMR expression patterns helps identify new therapeutic targets and biomarkers. OSMR research continues to uncover novel insights into cellular communication and disease development. Santa Cruz Biotechnology monoclonal antibodies for OSMR support cutting-edge research that advances scientific understanding of human health and disease.